Carl Zeiss Vision, MaximEyes announce product integration

January 27, 2012

Carl Zeiss Vision, a worldwide leader in developing and manufacturing ophthalmic lenses, lens coatings and dispensary technologies, and First Insight Corporation, developer of MaximEyes 11.0 practice management and MaximEyes SQL-certified electronic health records software for optometrists and ophthalmologists, recently unveiled a direct integration with MaximEyes 11.0 and Carl Zeiss Vision’s i.Profiler plus and i.Scription.

i.Scription is a revolutionary method of optical calculation that optimizes a patient’s prescription based upon the total wavefront aberrations of each eye as measured by the i.Profilerplus.

By optimizing a prescription for the eye’s total wavefront aberrations, including both the “low-order” and “high-order” aberrations in conjunction with a subjective refraction, i.Scription can significantly enhance overall visual performance including visual acuity, contrast sensitivity, and depth perception, particularly at night and in low-light viewing conditions.

The i.Profilerplus offers a variety of diagnostic capabilities that are invaluable tools in a variety of clinical applications: evaluating the complete refractive status of the eye, including low- and high-order wavefront aberrations; fitting soft and rigid contact lenses; monitoring ocular disease processes; and managing or co-managing refractive and surgical interventions.

Ocular wavefront data captured by the i.Profilerplus is also used to calculate an i.Scription, which is a wavefront-guided spectacle correction that offers enhanced visual performance over a range of viewing conditions.

This two-way integration eliminates the need to re-key data with just a few clicks, said Nitin Rai, First Insight’s President/CEO.

“Practices can export patient demographics to the i.Profiler plus equipment and import i.Profiler autorefractor data into a MaximEyes medical exam record if wavefront measurement data is available. The optimized Final Rx data from i.Scription can be easily imported back into a MaximEyes medical exam record. In addition, this integration will function in a Terminal Server environment,” said Rai.

“As increasing numbers of practices incorporate i.ProfilerPlus and i.Scription into their exam protocol, integration with patients’ medical records becomes more important,” said Joe Donahoe, Carl Zeiss Vision’s president-North America. “This integration with MaximEyes, one of the leading systems available today, is a significant milestone in the growth of i.Scription technology.”

For more information, visit www.vision.zeiss.com or  www.first-insight.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: